Media Update, page-10

I would think this is a positive on a couple of fronts

1) the US approval was noted as 'pending' in the Sep 29th announcement that Atomo can market this test in AU/NZ/India; this US approval gives the product credibility and therefore will increase market opportunity for Atomo in AU/NZ/India

2) AccessBio is really having the runs on the board; since end of July their share price is up 300 to 400%; it means a close partner of Atomo is doing really, really well; this should be good for us long term; and Atomo said a priority was choosing partners wisely

Surely, the US approval for our Ab test must be sooooooooooooooooonnnnn.

re reading the Sep 29 announcement, since Atomo have the only pair of tests for use in Australia. Mind you, we still need approval for this antigen test use in Australia. We have approval for antibody. The pair seems quite a simple opportunity, as noted in the 29 Sept announcement: testing for antigen and antibody can be done in one hit (here in Oz) for a patient; patient has a free (govt provided) cup of coffee and waits for results.